Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab.
作者信息
Facheris Paola, Valenti Mario, Pavia Giulia, Gargiulo Luigi, Narcisi Alessandra, Costanzo Antonio, Borroni Riccardo G
机构信息
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy.
Dermatology, Humanitas Clinical and Research Center - IRCCS, Rozzano, MI, Italy.
出版信息
Int J Dermatol. 2020 Aug;59(8):e267-e268. doi: 10.1111/ijd.15008. Epub 2020 Jun 18.
Abstract
摘要
相似文献
1
Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab.一名使用司库奇尤单抗治疗的银屑病患者发生的复杂型2019冠状病毒病（COVID-19）
Int J Dermatol. 2020 Aug;59(8):e267-e268. doi: 10.1111/ijd.15008. Epub 2020 Jun 18.
2
COVID-19 serologic testing: FAQs and caveats.新型冠状病毒肺炎血清学检测：常见问题及注意事项
Cleve Clin J Med. 2020 Jun;87(6):329-333. doi: 10.3949/ccjm.87a.20054. Epub 2020 May 20.
3
COVID-19 in Pediatrics: A Laboratory Perspective.儿科中的新型冠状病毒肺炎：实验室视角
J Appl Lab Med. 2020 Jul 1;5(4):824-828. doi: 10.1093/jalm/jfaa065.
4
Analysis of clinical features of COVID-19 in cancer patients.癌症患者中新型冠状病毒肺炎的临床特征分析
Acta Oncol. 2020 Nov;59(11):1393-1396. doi: 10.1080/0284186X.2020.1810313. Epub 2020 Aug 28.
5
SARS-CoV-2 in upper and lower airway samples of a laryngectomized patient: New insights and many lessons.喉切除患者上呼吸道和下呼吸道样本中的 SARS-CoV-2：新的认识和许多教训。
Oral Oncol. 2020 Aug;107:104841. doi: 10.1016/j.oraloncology.2020.104841. Epub 2020 Jun 4.
6
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice.迈向严重急性呼吸综合征冠状病毒2血清学检测在临床实践中的合理应用。
Clin Chem Lab Med. 2020 Sep 25;58(10):e189-e191. doi: 10.1515/cclm-2020-0880.
7
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn.可能存在感染 SARS-CoV-2 的母亲将病毒垂直传播给新生儿的情况。
JAMA. 2020 May 12;323(18):1846-1848. doi: 10.1001/jama.2020.4621.
8
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.银屑病和特应性皮炎中新型冠状病毒肺炎病例的全球报告：大流行期间为医疗护理提供信息的一个契机。
Br J Dermatol. 2020 Aug;183(2):404-406. doi: 10.1111/bjd.19161. Epub 2020 Jun 10.
9
Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.新冠病毒肺炎患者中抗SARS-CoV-2总抗体对核衣壳抗原的反应：一项纵向研究
Clin Chem Lab Med. 2020 Sep 25;58(10):e193-e196. doi: 10.1515/cclm-2020-0962.
10
COVID-19: Main therapeutic options.新型冠状病毒肺炎：主要治疗选择
Tunis Med. 2020 Apr;98(4):299-303.
引用本文的文献
1
Weathering the Storm: How Age and Biologics Influence the COVID-19 Cytokine Surge.经受住风暴：年龄和生物制剂如何影响COVID-19细胞因子风暴
Pathogens. 2025 Apr 3;14(4):346. doi: 10.3390/pathogens14040346.
2
Transition from secukinumab to adalimumab in COVID-19-induced psoriasis flare-up treatment: A case report.在新冠病毒诱导的银屑病发作治疗中从司库奇尤单抗转换为阿达木单抗：一例病例报告
Clin Case Rep. 2023 Oct 11;11(10):e8047. doi: 10.1002/ccr3.8047. eCollection 2023 Oct.
3
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials.比美吉珠单抗治疗中度至重度斑块状银屑病：一项随机临床试验的荟萃分析
Ther Adv Chronic Dis. 2023 Apr 4;14:20406223231163110. doi: 10.1177/20406223231163110. eCollection 2023.
4
Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis.银屑病患者接受白细胞介素-17 抑制剂治疗后感染 COVID-19、住院和死亡的风险：系统评价和荟萃分析。
Front Immunol. 2022 Oct 21;13:1046352. doi: 10.3389/fimmu.2022.1046352. eCollection 2022.
5
What Can IBD Specialists Learn from IL-23 Trials in Dermatology?炎症性肠病（IBD）专家长能从皮肤科的白细胞介素-23（IL-23）试验中学到什么？
J Crohns Colitis. 2022 May 11;16(Supplement_2):ii20-ii29. doi: 10.1093/ecco-jcc/jjac023.
6
Erythrodermic flare-up of psoriasis with COVID-19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID-19 on each other along with the special challenges of the pandemic.银屑病红皮病型发作合并新型冠状病毒肺炎感染：两例报告及文献综述，重点关注银屑病与新型冠状病毒肺炎的相互影响以及疫情带来的特殊挑战
Clin Case Rep. 2022 Apr 20;10(4):e05722. doi: 10.1002/ccr3.5722. eCollection 2022 Apr.
7
Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals-Prospective observational cohort study.中重度银屑病患者接受系统生物制剂治疗后抗 SARS-CoV-2 mRNA 疫苗接种的血清转化率：前瞻性观察队列研究。
Dermatol Ther. 2022 May;35(5):e15408. doi: 10.1111/dth.15408. Epub 2022 Mar 5.
8
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options.炎症途径与 COVID-19 的相互作用：发病机制和治疗选择的批判性综述。
Microb Pathog. 2021 Jan;150:104673. doi: 10.1016/j.micpath.2020.104673. Epub 2020 Dec 2.
9
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.国家银屑病基金会 COVID-19 工作组关于大流行期间银屑病管理的指南：第 1 版。
J Am Acad Dermatol. 2020 Dec;83(6):1704-1716. doi: 10.1016/j.jaad.2020.09.001. Epub 2020 Sep 4.
10
Biologic drugs during COVID-19 outbreak.2019冠状病毒病疫情期间的生物药物
Int J Dermatol. 2020 Oct;59(10):1293. doi: 10.1111/ijd.15088. Epub 2020 Aug 6.
本文引用的文献
1
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?我们能否使用白细胞介素 6（IL-6）阻断剂治疗 2019 冠状病毒病（COVID-19）引起的细胞因子释放综合征（CRS）？
J Autoimmun. 2020 Jul;111:102452. doi: 10.1016/j.jaut.2020.102452. Epub 2020 Apr 10.
2
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
3
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile.人类中东呼吸综合征冠状病毒感染与促炎 Th1 和 Th17 细胞因子谱有关。
Cytokine. 2018 Apr;104:8-13. doi: 10.1016/j.cyto.2018.01.025. Epub 2018 Feb 2.
Zotero 插件